<DOC>
	<DOCNO>NCT01299766</DOCNO>
	<brief_summary>The goal study determine whether increase participation cognitive , physical , and/or social activity prevents cognitive decline old African Americans ( AAs ) Mild Cognitive Impairment ( MCI ) . Patients MCI increase risk Alzheimer 's Disease ( AD ) ; propose increase participation activity prevent cognitive decline may delay onset Alzheimer 's Disease ( AD ) . We test hypothesis conduct clinical trial old AAs MCI ( age 65 year old ) randomize Behavior Activation ( BA ) ( behavioral intervention increase participation daily activity ) Supportive Therapy ( ST ) ( person-centered psychotherapy involve active listen offer support focus participant ' problem concern ) . We hypothesize BA-treated subject few decline cognitive functional ability , few depressive neuropsychiatric symptom , good quality life ST-treated subject 24 month .</brief_summary>
	<brief_title>Preventing Cognitive Decline African Americans With Mild Cognitive Impairment</brief_title>
	<detailed_description>The goal study determine whether increase participation activity prevent cognitive decline old African Americans Mild Cognitive Impairment ( MCI ) . We attempt increase activity Behavioral Activation ( BA ) . BA manual-based , behavioral treatment increase activity way improve function mood . As patient ( activation ) perceive benefit ( i.e. , feel well ) , activity level increase . BA promote activity reflect individual 's preference goal structure , scheduling , reinforce daily activity . This increase participation activity strong personal value , social engagement normative role function , turn enhances mood motivation remain active . The control treatment Supportive Therapy , non-directive , supportive therapy base empathy , reflection , support . This study specifically target old African Americans ( AAs ) . Most clinical trial MCI test pharmacologic treatment enrol mostly Whites ; result may apply AAs whose life experience medical genetic characteristic may exert unique effect . Those MCI high-risk population intervention prevent cognitive decline particularly important . Because AAs comprise one large minority group U.S. , suffer disparity health outcome , unlikely seek pharmacologic treatment participate clinical drug trial , urgent need enroll old AAs non-pharmacologic intervention study cognition . We recruit 200 AA subject age 65 old amnestic Mild Cognitive Impairment ( MCI ) - Multiple Domain subtype MCI ( aMCI-MD ) . One inclusion criterion participant Knowledgeable Informant ( KI ) willing participate study ( subject 's permission document informed consent form ) . A KI define family member friend identify subject someone regular frequent contact subject ( least twice per week ) in-person phone . The KI ask provide information regard subject 's functioning .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Age 65 year old Having friend/relative willing serve Knowledgeable Informant ( KI ) Diagnosis aMCIMD Selfidentified African American Psychiatric diagnosis , include dementia major depression Sensory deficit preclude neuropsychological test Institutional residence Reduced life expectancy due know terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Memory</keyword>
</DOC>